EX-106

N/A

Report date: 2026/04/20 20:01:59

Base Information

Drug NameEX-106
Drug Alias NameEX-106EX106
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > T cell engagers
Mechanisms of ActionAnti-Glypican-3Anti-CD3
TargetsGlypican-3T cell surface glycoprotein CD3
Therapy Area/IndicationsLiver Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesGuangzhou Excelmab Inc
China Registration ClassN/A

Develop Information

Active CompaniesGuangzhou Excelmab Inc
Inactive CompaniesN/A
Active IndicationsLiver Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A